Home
>
National Drug Code (NDC)
>
Glyburide
Glyburide - 0615-1556-31 - (Glyburide)
Drug Information of Glyburide
| Product NDC: | 0615-1556 |
| Proprietary Name: | Glyburide |
| Non Proprietary Name: | Glyburide |
| Active Ingredient(s): | 5 mg/1 & nbsp; Glyburide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glyburide
| Product NDC: | 0615-1556 |
| Labeler Name: | NCS HealthCare of KY, Inc dba Vangard Labs |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074388 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19950830 |
Package Information of Glyburide
| Package NDC: | 0615-1556-31 |
| Package Description: | 31 TABLET in 1 BLISTER PACK (0615-1556-31) |
NDC Information of Glyburide
| NDC Code | 0615-1556-31 |
| Proprietary Name | Glyburide |
| Package Description | 31 TABLET in 1 BLISTER PACK (0615-1556-31) |
| Product NDC | 0615-1556 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glyburide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19950830 |
| Marketing Category Name | ANDA |
| Labeler Name | NCS HealthCare of KY, Inc dba Vangard Labs |
| Substance Name | GLYBURIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
